Bausch Health Companies (BHC)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

2150 ST. ELZEAR BLVD. WEST QUEBEC, QUEBEC, CANADA H7L 4A8

Valeant Pharmaceuticals International is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Co.'s specialty pharmaceutical and over-the-counter (OTC) products are marketed under brand names across the U.S., Canada, Australia and New Zealand. Co. also has branded generic, branded, and OTC operations in Europe, Latin America, South East Asia and South Africa. As of Dec 31 2011, Co.'s product portfolio comprises of 900 products, with about 4,100 stock keeping units. Co.'s segments are: U.S. Neurology and Other; U.S. Dermatology; Canada and Australia; Branded Generics Europe; and Branded Generics Latin America.

Data based on most recent fiscal year report
Market Cap5.462 Billion Shares Outstanding348.59 Million Avg Volume26.771 Million
1-Yr BETA vs S&P TR Current Ratio1.11 Quick Ratio0.87
View SEC Filings from BHC instead.
Q3 2018 All Institutions Hedge Funds 1
To trade BHC now:
Filers who had this stock in their top 10: 13 9 (0.87%)
13F Filers holding this stock: 327 52 (5.02%)
Aggregate 13F shares on 09/30/2018: 174.936 Million 64.895 Million
Aggregate 13F shares on 06/30/2018: 150.907 Million 58.82 Million
Percent change: 15.92% 10.33%
Funds creating new positions: 79 20
Funds Adding to an existing position: 81 8
Funds closing out their position: 53 15
Funds reducing their position: 104 16
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding BHC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to

Exclude:

Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

25.4 Thousand total shares from 1 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL

  • Officer
48,010 2019-01-08 4

APPIO THOMAS PRES&CO-HEAD BAUSCH&LOMB/INT'L

  • Officer
152,640 2019-01-08 5

ELDESSOUKY SAM SVP, CHIEF ACCOUNTING OFFICER

  • Officer
61,421 2019-01-08 3

MCKENNA MARK C. PRESIDENT, SALIX

  • Officer
19,941 2019-01-08 2

GORDON JOSEPH F PRES&CO-HEAD BAUSCH&LOMB/INT'L

  • Officer
38,225 2019-01-08 2

HUMPHRIES WILLIAM D. PRESIDENT, ORTHO-DERMATOLOGICS

  • Officer
101,797 2019-01-03 1

CHAUDHURI BHASKAR

  • Director
0 2019-01-02 0

JORN DEBORA

  • Director
29,829 2018-12-31 0

WECHSLER AMY B

  • Director
73,165 2018-12-31 6

ROBERTSON RUSSEL C

  • Director
77,377 2018-12-31 6

DE SCHUTTER RICHARD U

  • Director
272,635 2018-12-31 10

PAULSON JOHN

  • Director
40,699 2018-12-31 7

VALUEACT HOLDINGS, L.P.

VALUEACT CAPITAL MASTER FUND, L.P.

VA PARTNERS I, LLC

VALUEACT CAPITAL MANAGEMENT, L.P.

VALUEACT CAPITAL MANAGEMENT, LLC

VALUEACT HOLDINGS GP, LLC

  • Director
  • SEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKS
27,295,160 2018-12-06 0

PROVENCIO NORMA ANN

  • Director
53,675 2018-11-15 0

STOLZ BRIAN M. CHIEF PEOPLE OFFICER

  • Officer
157,120 2018-11-12 0

PERSHING SQUARE CAPITAL MANAGEMENT, L.P.

PS MANAGEMENT GP, LLC

ACKMAN WILLIAM A

  • Director
1,233,589 2018-11-08 0

BOZE BRANDON

  • Director
0 2018-11-01 0

LAIDLEY DAVID H.

  • Director
70,156 2018-10-30 0

VON ESCHENBACH ANDREW C.

  • Director
1,000 2018-10-29 2

INGRAM ROBERT ALEXANDER

  • Director
77,710 2018-10-17 0

PAPA JOSEPH C CHAIRMAN & CEO

  • Officer
  • Director
687,077 2018-09-14 4

HERENDEEN PAUL EVP AND CFO

  • Officer
226,866 2018-09-14 4

WHITAKER ANNE CLEM

  • Director
30,653 2018-09-01 0

ULLIAN ELAINE

  • Director
7,626 2018-08-06 0

ESHELMAN FREDRIC N

  • Director
  • 10% Owner
1,596,546 2018-07-24 1

HASSAN FRED

0 2018-06-14 0

WECHSLER DANIEL MARK SEE REMARKS

  • Officer
  • Director
0 2018-06-12 0

KARABELAS ARGERIS N

0 2018-05-25 2

PARRISH MARK W

  • Director
54,059 2018-05-15 0

PAUL LAURENCE E

  • Director
23,131 2018-05-09 0

MELAS KYRIAZI THEO

  • Director
0 2018-05-08 0

POWER ROBERT N

  • Director
72,109 2018-05-03 2

HALE DAVID ROBERT

VALUEACT HOLDINGS, L.P.

VALUEACT CAPITAL MASTER FUND, L.P.

VALUEACT CO-INVEST MASTER FUND, L.P.

VA PARTNERS I, LLC

VALUEACT CAPITAL MANAGEMENT, L.P.

VALUEACT CAPITAL MANAGEMENT, LLC

VALUEACT HOLDINGS GP, LLC

  • Director
  • SEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKS
18,047,434 2018-05-03 3

ROSS THOMAS W. SR.

  • Director
66,169 2018-05-03 2

KAVANAGH SARAH B

  • Director
53,745 2018-05-03 2

GOGGINS COLLEEN A

  • Director
4,281 2018-04-26 0

MORFIT G MASON

VALUEACT HOLDINGS, L.P.

VALUEACT CAPITAL MASTER FUND, L.P.

VALUEACT CO-INVEST MASTER FUND, L.P.

VA PARTNERS I, LLC

VALUEACT CAPITAL MANAGEMENT, L.P.

VALUEACT CAPITAL MANAGEMENT, LLC

VALUEACT HOLDINGS GP, LLC

  • Director
  • SEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKS
No longer subject to file 2017-11-28 0

FRAIDIN STEPHEN

  • SEE REMARKS
No longer subject to file 2017-05-02 0

VALUEACT HOLDINGS, L.P.

VALUEACT CAPITAL MASTER FUND, L.P.

VALUEACT CO-INVEST MASTER FUND, L.P.

VA PARTNERS I, LLC

VALUEACT CAPITAL MANAGEMENT, L.P.

VALUEACT CAPITAL MANAGEMENT, LLC

VALUEACT HOLDINGS GP, LLC

  • Director
  • SEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKS
17,997,224 2017-03-14 0

KELLEN ARI EVP, COMPANY GROUP CHAIRMAN

  • Officer
630,842 2016-12-05 0

ROSIELLO ROBERT L. EVP, CORP DEV & STRATEGY

  • Officer
517,683 2016-12-05 0

KORNWASSER LAIZER

  • Director
No longer subject to file 2016-12-03 0

CHAI-ONN ROBERT ROSWELL EVP, CLO, GENERAL COUNSEL

  • Officer
124,815 2016-05-12 0

FARMER RONALD HAROLD

  • Director
38,447 2016-05-02 0

DE SILVA RAJIV PRESIDENT & CEO

  • Officer
  • Director
355,010 2016-03-18 0

HALL SUSAN EVP, CSO, GLOBAL HEAD OF R&D

  • Officer
4,826 2016-03-11 0

SCHILLER HOWARD BRADLEY CHAIRMAN AND CEO

  • Officer
  • Director
336,784 2016-02-18 0

PEARSON J. MICHAEL CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2015-12-31 0

HANSON JASON DAVID EVP, STRATEGY, CORP DEV & GC

  • Officer
500 2015-11-30 0

MIROVSKY PAVEL EVP, PRES. & GM VALEANT EMENA

  • Officer
69,525 2015-06-23 0

WELLS WILLIAM MCDOWALL

0 2015-06-15 0

UBBEN JEFFREY W

VALUEACT HOLDINGS, L.P.

VALUEACT CAPITAL MASTER FUND, L.P.

VALUEACT CO-INVEST MASTER FUND, L.P.

VA PARTNERS I, LLC

VALUEACT CAPITAL MANAGEMENT, L.P.

VALUEACT CAPITAL MANAGEMENT, LLC

VALUEACT HOLDINGS GP, LLC

  • Director
  • SEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKS
14,994,261 2015-06-10 0

STEVENSON KATHARINE BERGHUIS

  • Director
24,705 2015-05-22 0

LONNER ANDERS

  • Director
29,891 2015-05-22 0

WELDON RYAN EVP, COMPANY GROUP CHAIRMAN

  • Officer
103,409 2014-04-28 0

SEGAL LLOYD MITCHELL

  • Director
21,174 2013-06-14 0

MORFIT G MASON

VALUEACT HOLDINGS, L.P.

VALUEACT CAPITAL MASTER FUND, L.P.

VA PARTNERS I, LLC

VALUEACT CAPITAL MANAGEMENT, L.P.

VALUEACT CAPITAL MANAGEMENT, LLC

VALUEACT HOLDINGS GP, LLC

  • Director
  • SEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKS
17,575,958 2013-06-04 0

KOPPES RICHARD

  • Director
0 2013-04-18 0

MORFIT G MASON

  • Director
81,106 2012-06-04 0

MASTERSON RICHARD KEVIN PRES. & COO, VALEANT INTL. BB

  • Officer
89,524 2012-05-10 0

LOBERG PHILIP WALDEN JR EVP, INTERIM CFO

  • Officer
145,065 2011-07-25 0

VAN EVERY MICHAEL ROBERT

  • Director
6,397 2011-05-19 0

DURHAM MARK ANDREW SVP HUMAN RESOURCES

  • Officer
61,595 2011-05-11 0

CHOUINARD MICHEL COO, BIOVAIL LABS. INTL SRL

  • Officer
0 2010-12-22 0

MULLIGAN MARGARET JEAN EVP, CFO

  • Officer
0 2010-11-11 0

FIBIGER HANS CHRISTIAN CHIEF SCIENTIFIC OFFICER

  • Officer
0 2010-10-04 0

MAYER CHRISTINE SVP, BTA PHARMACEUTICALS, INC.

  • Officer
0 2010-10-04 0

KUGELMAN LARRY

  • Director
No longer subject to file 2010-09-28 0

KARLSON ELISA A. EVP, CHIEF ADMIN OFFICER

  • Officer
No longer subject to file 2010-09-28 0

MIN STEVE T. EVP, GENERAL COUNSEL

  • Officer
No longer subject to file 2010-09-28 0

BLOTT PETER J EVP, CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2010-09-28 0

STEFANO STEPHEN F.

  • Director
No longer subject to file 2010-09-28 0

GOUIN SERGE

  • Director
0 2010-07-05 0

POTTER FRANK

  • Director
0 2010-07-05 0

LANTHIER JOHN SPENCER

  • Director
0 2010-07-05 0

GODIN GILBERT EVP & COO

  • Officer
0 2010-07-05 0

GUBITZ GREGORY DAVID SVP, CORP. DEVEL. & GC

  • Officer
0 2010-07-05 0

SQUIRES DOUGLAS JOHN PAUL

  • Director
0 2010-07-05 0

TULL LOUIS RANDALL

  • Director
0 2010-07-05 0

HEALTHCOR MANAGEMENT, L.P.

HEALTHCOR CAPITAL, L.P.

HEALTHCOR ASSOCIATES, LLC

HEALTHCOR GROUP, LLC

HEALTHCOR L P

COHEN ARTHUR BRUCE

HEALEY JOSEPH PATRICK

  • 10% Owner
No longer subject to file 2009-11-18 0

HEALTHCOR OFFSHORE GP, LLC

HEALTHCOR HYBRID OFFSHORE GP, LLC

HEALTHCOR HYBRID OFFSHORE MASTER FUND, L.P.

HEALTHCOR OFFSHORE MASTER FUND, L.P.

  • 10% Owner
No longer subject to file 2009-11-18 0

HEALTHCOR MANAGEMENT, L.P.

HEALTHCOR CAPITAL, L.P.

HEALTHCOR HYBRID OFFSHORE

HEALTHCOR ASSOCIATES, LLC

HEALTHCOR GROUP, LLC

HEALTHCOR OFFSHORE, LTD.

HEALTHCOR L P

COHEN ARTHUR BRUCE

HEALEY JOSEPH PATRICK

  • Director
  • 10% Owner
0 2009-07-23 0

VALUEACT HOLDINGS, L.P.

VA PARTNERS I, LLC

VA PARTNERS III, LLC

VALUEACT CAPITAL MANAGEMENT, L.P.

VALUEACT CAPITAL MANAGEMENT, LLC

VALUEACT HOLDINGS GP, LLC

  • 10% Owner
No longer subject to file 2009-06-01 0

VALUEACT HOLDINGS, L.P.

VA PARTNERS I, LLC

VALUEACT CAPITAL MANAGEMENT, L.P.

VALUEACT CAPITAL MANAGEMENT, LLC

VALUEACT HOLDINGS GP, LLC

  • 10% Owner
  • SEE REMARKS BELOWSEE REMARKS BELOWSEE REMARKS BELOWSEE REMARKS BELOWSEE REMARKS BELOW
15,833,193 2009-05-15 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

APPIO THOMAS - Officer PRES&CO-HEAD BAUSCH&LOMB/INT'L

2019-01-08 F 1,722 $21.25 d 152,640 152,640.00 direct

MCKENNA MARK C. - Officer PRESIDENT, SALIX

2019-01-08 F 1,190 $21.25 d 19,941 19,941.00 direct

ELDESSOUKY SAM - Officer SVP, CHIEF ACCOUNTING OFFICER

2019-01-08 F 1,696 $21.25 d 61,421 61,421.00 direct

ACKERMANN CHRISTINA - Officer EVP AND GENERAL COUNSEL

2019-01-08 F 3,446 $21.25 d 48,010 48,010.00 direct

GORDON JOSEPH F - Officer PRES&CO-HEAD BAUSCH&LOMB/INT'L

2019-01-08 F 2,169 $21.25 d 38,225 38,225.00 direct

HUMPHRIES WILLIAM D. - Officer PRESIDENT, ORTHO-DERMATOLOGICS

2019-01-03 F 13,311 $18.47 d 101,797 101,797.00 direct

PAULSON JOHN - Director

2018-12-31 A 1,488 $18.47 a 40,699 40,699.00 direct

ROBERTSON RUSSEL C - Director

2018-12-31 A 2,210 $18.47 a 77,377 77,377.00 direct

DE SCHUTTER RICHARD U - Director

2018-12-31 A 1,691 $18.47 a 262,635 272,635.00 direct

WECHSLER AMY B - Director

2018-12-31 A 1,716 $18.47 a 73,165 73,165.00 direct

APPIO THOMAS - Officer PRES&CO-HEAD BAUSCH&LOMB/INT'L

2018-12-14 P 25,440 $22.96 a 128,922 154,362.00 direct

APPIO THOMAS - Officer PRES&CO-HEAD BAUSCH&LOMB/INT'L

2018-12-14 A 25,440 a 154,362 154,362.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments